Celsense, Inc., a biotechnology company working in the cellular imaging space offers magnetic resonance imaging (MRI) contrast agents that enable scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo. The firm's products include Cell Sense, a MRI cell tracer reagent; Gene Sense, a proprietary DNA-encoded marker that genetically programs cells to express their own contrast agent; V-sense, a fluorine-based MRI tracer agent, as well as Workstation software platform, a Windows based image management system; and Voxel Tracker that allows researchers to manipulate and quantify molecular imaging data by merging images produced from various imaging scanners. The company’s products are used to monitor the inflammation and administration of cellular therapeutics, such as regenerative cell therapies that repair damaged and diseased organs and immunologic therapies to treat cancer. Its products are also used as in vivo diagnostics to track cancer metastases and immune system response.Celsense was founded to commercialize imaging platforms developed at Carnegie Mellon University.
